Journal article 147 views 5 downloads
Bromodomain inhibitor i-BET858 triggers a unique transcriptional response coupled to enhanced DNA damage, cell cycle arrest and apoptosis in high-grade ovarian carcinoma cells
Clinical Epigenetics, Volume: 15, Issue: 1
Swansea University Authors:
Marcos Quintela Vazquez, David James, Agne Pociute, Lydia Powell , Kadie Edwards
, Zoe Coombes, Kerryn Lutchman-Singh, Lavinia Margarit, Steve Conlan
, Lewis Francis
-
PDF | Version of Record
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Download (7.96MB)
DOI (Published version): 10.1186/s13148-023-01477-x
Abstract
Bromodomain inhibitor i-BET858 triggers a unique transcriptional response coupled to enhanced DNA damage, cell cycle arrest and apoptosis in high-grade ovarian carcinoma cells
Published in: | Clinical Epigenetics |
---|---|
ISSN: | 1868-7083 |
Published: |
Springer Science and Business Media LLC
2023
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa63494 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Keywords: |
Ovarian cancer, BETi , Advanced therapeutics, Drug development, i-BET858 |
---|---|
College: |
Faculty of Medicine, Health and Life Sciences |
Issue: |
1 |